Fredonia, NY, United States of America

Carl Morrison

USPTO Granted Patents = 3 

Average Co-Inventor Count = 5.1

ph-index = 1


Company Filing History:


Years Active: 2022-2025

Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Carl Morrison

Introduction

Carl Morrison is a notable inventor based in Fredonia, NY (US). He has made significant contributions to the field of personalized therapies, holding a total of 3 patents. His work focuses on developing methods that enhance the understanding and application of immune scores in therapeutic settings.

Latest Patents

Morrison's latest patents include innovative methods and systems for determining personalized therapies. One of his key patents outlines a method for generating an immune score, which involves several steps. These steps include determining a qualitative and/or quantitative assessment of tumor infiltrating lymphocytes in a sample, assessing T-cell receptor signaling, and evaluating mutation burden. The method culminates in generating an immune score using a predictive algorithm based on these assessments.

Career Highlights

Carl Morrison is currently associated with Omniseq, Inc., where he continues to push the boundaries of medical technology. His work is instrumental in advancing personalized medicine, particularly in oncology. His innovative approaches have the potential to significantly impact patient care and treatment outcomes.

Collaborations

Morrison collaborates with talented professionals in his field, including Sarabjot Pabla and Jeffrey Conroy. These collaborations enhance the research and development efforts at Omniseq, Inc., fostering an environment of innovation and discovery.

Conclusion

Carl Morrison's contributions to the field of personalized therapies exemplify the impact of innovation in medicine. His patents and ongoing work at Omniseq, Inc. highlight the importance of advancing therapeutic methods to improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…